ALNYLAM PHARMACEUTICALS, INC. Intellectual Property Contracts & Agreements

40 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to License and Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and The Medicines Company
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2023
License and Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and The Medicines Company
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Cross-License Agreement among Alnylam Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corporation, and Protiva Biotherapeutics Inc. dated November 12, 2012
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2023
Patent Cross-License Agreement between Dicerna Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. dated April 3, 2020
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Amendment to License and Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and The Medicines Company
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2020
Amended and Restated ALN-AT3 Global License Agreement between Alnylam Pharmaceuticals, Inc. and Genzyme Corporation (April 8, 2019)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2019
ALN-AT3 Global License Agreement between Alnylam Pharmaceuticals, Inc. and Genzyme Corporation (January 6, 2018)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2018
Exclusive License Agreement between Alnylam Pharmaceuticals, Inc. and Genzyme Corporation
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2018
Exclusive License Agreement for Tuschl II U.S. Patents between Alnylam Pharmaceuticals, Inc. and University of Massachusetts
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2015
License and Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and The Medicines Company (2013)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2013
Cross-License Agreement among Alnylam Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corporation, and Protiva Biotherapeutics Inc. dated November 12, 2012
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2013
License and Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and Genzyme Corporation
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2013
Amendment to Strategic Collaboration and License Agreement between Isis Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2012
License and Collaboration Agreement between Monsanto Company and Alnylam Pharmaceuticals, Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2012
Amendment to Co-Exclusive License Agreement among Alnylam Pharmaceuticals, MIT, Whitehead Institute, and Max-Planck-Innovation
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2011
Exclusive License Agreement for Tuschl II U.S. Patents between Alnylam Pharmaceuticals, Inc. and University of Massachusetts
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2011
License and Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and Kyowa Hakko Kogyo Co., Ltd.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2011
Amended and Restated Cross-License Agreement between Alnylam Pharmaceuticals, Inc. and Protiva Biotherapeutics Inc. (May 30, 2008)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2011
Amended and Restated License and Collaboration Agreement between Tekmira Pharmaceuticals Corporation and Alnylam Pharmaceuticals, Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2011
Sublicense Agreement between Alnylam Pharmaceuticals, Inc. and Inex Pharmaceuticals Corporation (January 8, 2007)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2011
First Amendment to License and Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and Cubist Pharmaceuticals, Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2010
License and Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and Cubist Pharmaceuticals, Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2009
License and Collaboration Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Alnylam Pharmaceuticals, Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2009
License and Collaboration Agreement among Alnylam Pharmaceuticals, Isis Pharmaceuticals, and Regulus Therapeutics (September 6, 2007)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2007
License and Collaboration Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Alnylam Pharmaceuticals, Inc. (July 8, 2007)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2007
Amended and Restated Research Collaboration and License Agreement between Merck & Co., Inc. and Alnylam Pharmaceuticals, Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2006
Addendum to Research Collaboration and License Agreement between Novartis Institutes for BioMedical Research, Inc. and Alnylam Pharmaceuticals, Inc. (Influenza Program)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2006
Research Collaboration and License Agreement between Novartis Institutes for BioMedical Research, Inc. and Alnylam Pharmaceuticals, Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2005
Co-Exclusive License Agreement between Stanford University and Alnylam Pharmaceuticals, Inc. for RNA Transfection Technology
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
CA
2004
Co-Exclusive License Agreement between Garching Innovation GmbH and Ribopharma AG
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2004
Co-Exclusive License Agreement between Garching Innovation GmbH and Alnylam Pharmaceuticals Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2004
License Agreement between Cold Spring Harbor Laboratory and Alnylam Pharmaceuticals, Inc. (RNAi Technologies)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2004
License Agreement between Cancer Research Technology Limited and Alnylam Pharmaceuticals, Inc. (July 18, 2003)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2004
Co-Exclusive License Agreement between Garching Innovation GmbH and Alnylam Pharmaceuticals Inc.
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2004
Co-Exclusive License Agreement between Stanford University and Alnylam Pharmaceuticals, Inc. for RNA Transfection Technology
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
CA
2004
Co-Exclusive License Agreement between Garching Innovation GmbH and Ribopharma AG (July 30, 2003)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2004
Co-Exclusive License Agreement between Garching Innovation GmbH and Alnylam Pharmaceuticals Inc. (12/20/2002)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2004
License Agreement between Cold Spring Harbor Laboratory and Alnylam Pharmaceuticals, Inc. (December 30, 2003)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2004
License Agreement between Carnegie Institution of Washington and RIBOPHARMA AG (March 1, 2002)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DC
2004
License Agreement between Cancer Research Technology Limited and Alnylam Pharmaceuticals, Inc. (July 18, 2003)
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2004